Treat to target in IBD: the idea behind modern monitoring

For many years, success in inflammatory bowel disease was judged by how the patient felt. If the diarrhoea settled and the pain eased, all was well. We now know that symptoms and inflammation do not always move together. A patient can feel well while inflammation continues to damage the bowel.

Treat to target is the response to that discovery. It means agreeing measurable goals at the start, checking them at planned times, and reviewing the plan with the IBD team when a goal is not met.

The targets

Targets are usually layered by time. In the short term the aim is relief of symptoms. Blood and stool markers of inflammation should then return to normal. In the longer term the aim is healing of the bowel lining, because mucosal healing is linked with fewer flares, fewer admissions and less surgery. Quality of life and the absence of disability sit alongside these goals.

How the targets are measured

Faecal calprotectin is the workhorse of monitoring. It is non-invasive, can be repeated, and often rises before symptoms return. C-reactive protein helps in some patients. Endoscopy remains the reference standard for assessing healing, and intestinal ultrasound and MR enterography are increasingly used to assess the small bowel in Crohn’s disease.

Why the idea matters

The value of treat to target lies in planning. Each check has a date, each result is compared with the agreed goal, and the patient knows what is being measured and why. It turns follow-up from waiting for the next flare into a structured conversation.

For exams and for practice

Treat to target is now part of the language of IBD in guidelines and in specialty exams. Physicians are expected to know what the targets are, how they are measured and how the scores used in IBD relate to them.

IBD for Clinicians explains the targets, the scores used to measure them and the monitoring tools in line with the 2025 BSG guideline.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *